Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion

NCT ID: NCT02290314

Last Updated: 2018-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Degenerative lumbar spondylolisthesis is the forward displacement (slip) of one vertebra on an adjacent vertebra resulting in narrowing of the spinal canal or compression of the exiting nerve roots. It is commonly associated with low back and leg pain, and is a frequent reason for spine surgery particularly in individuals over age 65 years. Recently novel minimally invasive surgical techniques have heightened public and government interest by touting benefits of reduced approached-related morbidity which in turn leads to quicker recovery, shorter hospital stay, improved short-term clinical outcomes, and reduced health care cost. However, there is no randomized controlled trial evidence to describe the actual advantages and disadvantages associated with minimally invasive spinal fusion. This pilot study is a randomized control trial comparing minimally invasive MID-line Lumbar Fusion (MIDLF) to traditional "open" posterior lumbar interbody fusion (PLIF) with respect to length of stay, approach related morbidity, patient centered outcome measures, and cost-effectiveness in the treatment of degenerative lumbar spondylolisthesis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Lumbar Spondylolisthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

minimally invasive MID-line Lumbar Fusion (MIDLF)

MIDLF surgery involves a minimally invasive midline laminectomy posterior approach to the lumbar spine. An incision that is smaller than the standard incision is made in the midline of the low back directly over the spinal levels. Afterward the pressure on the compressed nerves is released, and the disc between the affected vertebrae is completely removed. A metal cage filled with bone graft is placed as described in the PLIF procedure.

Group Type OTHER

minimally invasive MID-line Lumbar Fusion (MIDLF)

Intervention Type PROCEDURE

posterior lumbar interbody fusion (PLIF)

PLIF surgery involves a standard incision in the midline of the low back directly over the involved spinal levels. Afterward the pressure on the compressed nerves is released, and the disc between the affected vertebrae is completely removed. A metal cage filled with bone graft is placed in between the vertebral bodies where the disc usually lies. This will allow bone fusion (healing) to occur from one vertebral body to the other.

Group Type OTHER

Posterior lumbar interbody fusion (PLIF)

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

minimally invasive MID-line Lumbar Fusion (MIDLF)

Intervention Type PROCEDURE

Posterior lumbar interbody fusion (PLIF)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients attending Victoria Hospital
* Degenerative spondylolisthesis in the lumbar spine at one level
* Medically Suitable for surgical management
* Able to consent for surgery

Exclusion Criteria

* Lytic spondylolisthesis
* Non degenerative stenosis: tumor, trauma
* Active infection
* On long term disability or workers compensation claims
* Drug or alcohol misuse
* Lack of permanent home residence
* Previous surgery in the lumbar spine at the surgical level
* Previous fusion in the lumbar spine
* Contraindication to surgery: medical co morbidities
* Unable to complete questionnaire: eg dementia
* Unable to give voluntary consent
* Pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The London Spine Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Christopher Bailey

Dr. Christopher Bailey

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chris Bailey

Role: PRINCIPAL_INVESTIGATOR

London Health Sciences Centre and Western University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

London Health Science Centre

London, Ontario, Canada

Site Status RECRUITING

London Health Sciences Centre

London, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jennifer Urquhart

Role: CONTACT

5196858500 ext. 53062

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

christopher S Bailey, MD

Role: primary

519-685-8500 ext. 55358

Christopher S Bailey, MD

Role: primary

519-685-8500 ext. 55358

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

105951

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OLIF25™ /OLIF51™ Study
NCT02657421 TERMINATED